Funding opportunities for junior faculty offered by the American Association for Cancer Research

August 15, 2003

The American Association for Cancer Research (AACR), the nation's largest and oldest professional society of basic, translational, and clinical cancer research scientists, is now accepting applications for the AACR-Gertrude B. Elion Cancer Research Award and AACR Career Development Awards in 2004.

The AACR-Gertrude B. Elion Cancer Research Award was established in honor of the late Nobel laureate Dr. Gertrude B. Elion, Past President and Honorary Member of the AACR. Dr. Elion was a Scientist Emeritus at Glaxo Wellcome, where she worked for almost 40 years. According to JP Garnier, Ph.D., Chief Executive Officer, GlaxoSmithKline, "Our support of the AACR-Gertrude B. Elion Cancer Research Award is one of the ways that we acknowledge the tremendous research efforts by oncology scientists everywhere to help bring hope to cancer patients as we relentlessly pursue cures."

This Award fosters meritorious basic, translational, or clinical cancer research by a tenure-track scientist at the level of Assistant Professor at an academic institution anywhere in the world. The one-year award carries a grant of $50,000 for salary, laboratory supplies, and limited domestic travel. The winner will be required to give a presentation of their research at the 2005 AACR Annual Meeting (April 16-20, 2005, Anaheim, California). Candidates must have completed postdoctoral studies or clinical fellowships no later than July 1 of the application year (2003), and ordinarily not more than five years prior to the award year (2004).

The application deadline is Friday, October 31, 2003.

The AACR Career Development Awards in Cancer Research are two-year awards of $50,000 per year that support research by scientists at an academic institution at the level of Instructor, Acting Assistant Professor, Assistant Professor, or the equivalent. Five Career Development Awards in the areas of translational lung cancer research, pancreatic cancer research, HER Family Pathway research, breast cancer research, and basic cancer research will be granted in 2004. The application deadline is Friday, November 14, 2003.

Career Development Awards for Instructors, Acting Assistant Professors, and Assistant Professors Candidates for the Awards in pancreatic research, HER Family Pathway research, and basic cancer research must be, by the start of the grant term (July 1, 2004), in the first, second, or third year of a full-time, faculty appointment and hold the title of Instructor, Acting Assistant Professor, Assistant Professor, or an equivalent full-time faculty appointment at an academic or medical institution. Certain geographic restrictions apply. Please refer to the AACR Website for details.

Career Development Awards for Assistant Professors

Candidates for the Awards in translational lung cancer research and breast cancer research must be, at the time of application (November 14, 2003), in their first or second year at the level of Assistant Professor or an equivalent full-time, tenure-track faculty appointment at an academic institution anywhere in the world.
The AACR acknowledges the generous support of the following funders of the 2004 AACR Career Development Awards: Cancer Research and Prevention Foundation, Genentech BioOncology, Susan G. Komen Breast Cancer Foundation, Pancreatic Cancer Action Network (PanCAN), and Pennsylvania Department of Health.

Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 20,000 laboratory and clinical scientists engaged in cancer research in the United States and more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). AACR's Annual Meeting attracts more than 16,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational and clinical cancer research.

American Association for Cancer Research

Related Cancer Research Articles from Brightsurf:

As cancer has evolved, it is time for cancer research to do the same
Marking Lung Cancer Awareness month, a new study investigates the extent to which human-based, non-animal approaches are supplanting animal models in cancer research - comparing number of publications, funding, and publications associated with clinical trials between xenograft models and human organoids.

New liver cancer research targets non-cancer cells to blunt tumor growth
'Senotherapy,' a treatment that uses small molecule drugs to target ''senescent'' cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models according to new research from a team led by Celeste Simon, PhD, a professor of Cell and Developmental Biology in the Perelman School of Medicine at the University of Pennsylvania and scientific director of the Abramson Family Cancer Research Institute.

Blueprint to beat cancer launched today by World Cancer Research Fund (WCRF)
Overweight and obesity increase cancer risk. A new report published today by World Cancer Research Fund (WCRF), and presented at the European Congress on Obesity in Vienna, shows that overweight or obesity is a cause of at least 12 cancers, five more than WCRF findings a decade ago.

Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

UA Cancer Center research team explores anti-breast cancer properties of soy
Genistein, a major compound in soy foods, might aid in the proper functioning of a gene that can malfunction to cause breast cancer.

Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.

The potential consequences for cancer care and cancer research of Brexit
Cancer leaders highlight main fears for patient care, treatment and research in a post-Brexit world.

Cancer Research UK announces Grand Challenge teams to answer biggest questions in cancer
Cancer Research UK today announces that four international teams are the first recipients of its global £100 million Grand Challenge competition, which aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.

Huntsman Cancer Institute research holds promise for personalized lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another.

Leading cancer research organizations to host cancer immunotherapy conference
The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will sponsor the second International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel (811 7th Ave., New York, NY 10019) and the New York Hilton Midtown ( 1335 Avenue of the Americas, New York, NY 10019), Sept.

Read More: Cancer Research News and Cancer Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to